Anis Karimpour-Fard
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 11 | 2024 | 700 | 1.090 |
Why?
| | Computational Biology | 9 | 2015 | 680 | 0.850 |
Why?
| | Cardiomyopathy, Dilated | 7 | 2025 | 359 | 0.830 |
Why?
| | Protein Interaction Mapping | 3 | 2008 | 103 | 0.590 |
Why?
| | Ventricular Remodeling | 4 | 2025 | 275 | 0.560 |
Why?
| | Software | 2 | 2015 | 690 | 0.530 |
Why?
| | Myocytes, Cardiac | 5 | 2026 | 551 | 0.520 |
Why?
| | Circulating MicroRNA | 3 | 2023 | 25 | 0.480 |
Why?
| | DNA Copy Number Variations | 2 | 2018 | 183 | 0.430 |
Why?
| | Hibernation | 5 | 2014 | 80 | 0.420 |
Why?
| | Proteomics | 6 | 2015 | 1191 | 0.410 |
Why?
| | Caloric Restriction | 2 | 2026 | 127 | 0.400 |
Why?
| | Phylogeny | 4 | 2014 | 1015 | 0.370 |
Why?
| | Comparative Genomic Hybridization | 2 | 2018 | 28 | 0.360 |
Why?
| | Gene Expression Profiling | 10 | 2021 | 1782 | 0.350 |
Why?
| | Sciuridae | 5 | 2014 | 152 | 0.350 |
Why?
| | Escherichia coli | 6 | 2012 | 852 | 0.330 |
Why?
| | Multigene Family | 3 | 2008 | 203 | 0.300 |
Why?
| | Cluster Analysis | 6 | 2021 | 519 | 0.290 |
Why?
| | Biomarkers | 7 | 2024 | 4254 | 0.290 |
Why?
| | Proteome | 3 | 2023 | 514 | 0.280 |
Why?
| | MAP Kinase Kinase Kinases | 2 | 2021 | 70 | 0.270 |
Why?
| | Sequence Analysis, Protein | 1 | 2007 | 33 | 0.270 |
Why?
| | Data Collection | 1 | 2010 | 633 | 0.260 |
Why?
| | Seasons | 5 | 2014 | 556 | 0.260 |
Why?
| | Ventricular Function, Left | 2 | 2025 | 538 | 0.260 |
Why?
| | Superoxide Dismutase | 2 | 2020 | 301 | 0.260 |
Why?
| | Gammaproteobacteria | 1 | 2007 | 13 | 0.250 |
Why?
| | DNA Helicases | 2 | 2021 | 143 | 0.250 |
Why?
| | Metabolic Networks and Pathways | 5 | 2017 | 187 | 0.250 |
Why?
| | Oligonucleotide Array Sequence Analysis | 7 | 2012 | 758 | 0.240 |
Why?
| | Algorithms | 3 | 2008 | 1834 | 0.240 |
Why?
| | Iodide Peroxidase | 1 | 2026 | 34 | 0.230 |
Why?
| | Genome, Bacterial | 4 | 2012 | 155 | 0.230 |
Why?
| | Signal Transduction | 4 | 2023 | 5221 | 0.230 |
Why?
| | Bacterial Proteins | 2 | 2010 | 954 | 0.230 |
Why?
| | Genome | 4 | 2014 | 306 | 0.220 |
Why?
| | Amniotic Fluid | 2 | 2024 | 79 | 0.220 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 194 | 0.210 |
Why?
| | Escherichia coli Proteins | 3 | 2012 | 206 | 0.210 |
Why?
| | Models, Biological | 2 | 2008 | 1820 | 0.200 |
Why?
| | Trophoblasts | 1 | 2026 | 216 | 0.200 |
Why?
| | Fetal Growth Retardation | 2 | 2026 | 587 | 0.190 |
Why?
| | Arousal | 3 | 2012 | 157 | 0.190 |
Why?
| | Fetal Blood | 1 | 2024 | 342 | 0.180 |
Why?
| | Perforator Flap | 1 | 2022 | 20 | 0.180 |
Why?
| | DNA-Binding Proteins | 3 | 2021 | 1497 | 0.180 |
Why?
| | Heart Failure | 3 | 2023 | 2314 | 0.180 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 219 | 0.170 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2023 | 145 | 0.170 |
Why?
| | Species Specificity | 6 | 2008 | 574 | 0.170 |
Why?
| | Transcriptome | 4 | 2021 | 1044 | 0.170 |
Why?
| | Heart Defects, Congenital | 2 | 2021 | 913 | 0.170 |
Why?
| | Bleomycin | 2 | 2020 | 253 | 0.170 |
Why?
| | Focal Adhesions | 1 | 2021 | 47 | 0.170 |
Why?
| | Hypotension | 1 | 2022 | 126 | 0.170 |
Why?
| | Animals | 26 | 2026 | 38030 | 0.170 |
Why?
| | Fetofetal Transfusion | 1 | 2021 | 26 | 0.170 |
Why?
| | Prostatic Neoplasms | 2 | 2021 | 974 | 0.170 |
Why?
| | Heart Rate | 1 | 2025 | 849 | 0.170 |
Why?
| | Milrinone | 1 | 2021 | 26 | 0.160 |
Why?
| | Genetic Variation | 4 | 2018 | 982 | 0.160 |
Why?
| | Mammaplasty | 1 | 2022 | 104 | 0.160 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2025 | 250 | 0.160 |
Why?
| | Phosphorylation | 3 | 2021 | 1732 | 0.160 |
Why?
| | Biological Products | 1 | 2023 | 251 | 0.160 |
Why?
| | Heart Transplantation | 2 | 2018 | 736 | 0.160 |
Why?
| | Evolution, Molecular | 4 | 2014 | 513 | 0.160 |
Why?
| | Calcium-Binding Proteins | 1 | 2021 | 219 | 0.160 |
Why?
| | Receptors, Androgen | 1 | 2021 | 153 | 0.150 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 91 | 0.150 |
Why?
| | RNA Interference | 1 | 2021 | 476 | 0.150 |
Why?
| | Myocardium | 2 | 2017 | 939 | 0.150 |
Why?
| | Keloid | 1 | 2019 | 8 | 0.150 |
Why?
| | Dermis | 1 | 2019 | 32 | 0.150 |
Why?
| | Chromatography, Liquid | 3 | 2016 | 454 | 0.140 |
Why?
| | Fever | 1 | 2020 | 311 | 0.140 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 23 | 0.140 |
Why?
| | Humans | 36 | 2026 | 144261 | 0.140 |
Why?
| | RNA, Messenger | 6 | 2024 | 2829 | 0.140 |
Why?
| | Mosaicism | 1 | 2018 | 73 | 0.140 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2603 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2026 | 1208 | 0.140 |
Why?
| | Fluorouracil | 1 | 2019 | 235 | 0.130 |
Why?
| | Inflammation | 2 | 2020 | 2877 | 0.130 |
Why?
| | Serum | 1 | 2018 | 56 | 0.130 |
Why?
| | Cardiomyopathies | 1 | 2021 | 337 | 0.130 |
Why?
| | Heart Ventricles | 2 | 2021 | 756 | 0.130 |
Why?
| | Extracellular Matrix | 1 | 2021 | 553 | 0.130 |
Why?
| | Female | 25 | 2026 | 77976 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2023 | 586 | 0.130 |
Why?
| | Databases, Genetic | 2 | 2015 | 248 | 0.130 |
Why?
| | Muscle Proteins | 2 | 2025 | 244 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2020 | 302 | 0.120 |
Why?
| | Mice | 11 | 2026 | 18329 | 0.120 |
Why?
| | Reference Values | 2 | 2008 | 797 | 0.120 |
Why?
| | Models, Genetic | 3 | 2008 | 535 | 0.120 |
Why?
| | Specimen Handling | 1 | 2018 | 185 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 5 | 2017 | 341 | 0.120 |
Why?
| | Plasma | 1 | 2018 | 224 | 0.120 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 297 | 0.120 |
Why?
| | Energy Metabolism | 3 | 2023 | 935 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 576 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2018 | 557 | 0.110 |
Why?
| | Calcium | 1 | 2021 | 1182 | 0.110 |
Why?
| | Ethanol | 2 | 2012 | 625 | 0.110 |
Why?
| | Hylobates | 1 | 2014 | 8 | 0.110 |
Why?
| | Karyotype | 1 | 2014 | 19 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2143 | 0.100 |
Why?
| | Down-Regulation | 2 | 2021 | 627 | 0.100 |
Why?
| | Fetus | 1 | 2018 | 803 | 0.100 |
Why?
| | Phenotype | 3 | 2025 | 3157 | 0.100 |
Why?
| | Case-Control Studies | 4 | 2024 | 3592 | 0.100 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2014 | 120 | 0.100 |
Why?
| | Heart | 2 | 2021 | 633 | 0.100 |
Why?
| | Pregnancy | 5 | 2026 | 7180 | 0.100 |
Why?
| | Metabolomics | 2 | 2016 | 726 | 0.090 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 29 | 0.090 |
Why?
| | Lipectomy | 1 | 2012 | 8 | 0.090 |
Why?
| | Mutation | 5 | 2023 | 4085 | 0.090 |
Why?
| | Drug Tolerance | 1 | 2012 | 100 | 0.090 |
Why?
| | Fasting | 1 | 2014 | 276 | 0.090 |
Why?
| | Amino Acids | 1 | 2016 | 521 | 0.090 |
Why?
| | Male | 18 | 2026 | 72035 | 0.090 |
Why?
| | Dog Diseases | 1 | 2012 | 70 | 0.090 |
Why?
| | Subcutaneous Fat | 1 | 2012 | 78 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2011 | 23 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2018 | 741 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 2023 | 1313 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 173 | 0.090 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 132 | 0.090 |
Why?
| | Abdomen | 1 | 2012 | 141 | 0.080 |
Why?
| | Gene Duplication | 3 | 2007 | 67 | 0.080 |
Why?
| | Gluconeogenesis | 1 | 2011 | 83 | 0.080 |
Why?
| | Bacterial Infections | 1 | 2012 | 246 | 0.080 |
Why?
| | Gene Dosage | 2 | 2010 | 148 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 706 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2447 | 0.080 |
Why?
| | Reproducibility of Results | 4 | 2018 | 3403 | 0.080 |
Why?
| | Ligases | 1 | 2010 | 37 | 0.080 |
Why?
| | Sigma Factor | 1 | 2010 | 43 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 249 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2016 | 917 | 0.080 |
Why?
| | Markov Chains | 1 | 2010 | 126 | 0.080 |
Why?
| | Pancreas | 1 | 2012 | 341 | 0.080 |
Why?
| | Glycolysis | 1 | 2011 | 339 | 0.070 |
Why?
| | Oligonucleotides | 1 | 2010 | 149 | 0.070 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 318 | 0.070 |
Why?
| | Child | 8 | 2022 | 22537 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2010 | 205 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 498 | 0.070 |
Why?
| | Prospective Studies | 4 | 2024 | 7970 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 612 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4556 | 0.070 |
Why?
| | Escherichia coli K12 | 1 | 2008 | 8 | 0.070 |
Why?
| | Genetic Enhancement | 1 | 2008 | 5 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2023 | 2182 | 0.070 |
Why?
| | Stroke Volume | 2 | 2025 | 648 | 0.070 |
Why?
| | Placenta | 2 | 2026 | 780 | 0.070 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3539 | 0.070 |
Why?
| | Biostatistics | 1 | 2008 | 19 | 0.070 |
Why?
| | DNA Repair | 1 | 2010 | 255 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2021 | 901 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 905 | 0.060 |
Why?
| | Adiposity | 1 | 2012 | 541 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2008 | 509 | 0.060 |
Why?
| | Protein Engineering | 1 | 2008 | 122 | 0.060 |
Why?
| | Computer Simulation | 2 | 2008 | 1025 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 396 | 0.060 |
Why?
| | Genomics | 1 | 2012 | 833 | 0.060 |
Why?
| | Shigella flexneri | 1 | 2007 | 15 | 0.060 |
Why?
| | Pneumonia | 1 | 2012 | 630 | 0.060 |
Why?
| | Primates | 1 | 2007 | 131 | 0.060 |
Why?
| | Databases, Protein | 1 | 2007 | 90 | 0.060 |
Why?
| | Macaca mulatta | 1 | 2007 | 191 | 0.060 |
Why?
| | Likelihood Functions | 1 | 2007 | 143 | 0.060 |
Why?
| | DNA Probes | 1 | 2006 | 59 | 0.060 |
Why?
| | Placentation | 1 | 2026 | 53 | 0.060 |
Why?
| | Triiodothyronine | 1 | 2026 | 54 | 0.060 |
Why?
| | Models, Statistical | 2 | 2008 | 677 | 0.060 |
Why?
| | Forecasting | 1 | 2007 | 388 | 0.060 |
Why?
| | Thyroid Hormones | 1 | 2026 | 66 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2026 | 5988 | 0.060 |
Why?
| | Liver | 1 | 2014 | 1884 | 0.060 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 36 | 0.050 |
Why?
| | Genome, Human | 1 | 2007 | 422 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2018 | 4146 | 0.050 |
Why?
| | Biopsy | 2 | 2019 | 1075 | 0.050 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 115 | 0.050 |
Why?
| | Sequence Analysis, DNA | 4 | 2010 | 824 | 0.050 |
Why?
| | Potassium Channels | 1 | 2025 | 145 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2525 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1495 | 0.050 |
Why?
| | Biofilms | 1 | 2007 | 278 | 0.050 |
Why?
| | Echocardiography | 2 | 2021 | 647 | 0.050 |
Why?
| | Models, Theoretical | 1 | 2007 | 582 | 0.050 |
Why?
| | Receptors, Adrenergic | 1 | 2023 | 20 | 0.050 |
Why?
| | Child, Preschool | 4 | 2021 | 11774 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 163 | 0.050 |
Why?
| | Phosphoproteins | 2 | 2019 | 343 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 195 | 0.050 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2014 | 110 | 0.050 |
Why?
| | Sarcomeres | 1 | 2023 | 98 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2111 | 0.050 |
Why?
| | Rats | 2 | 2021 | 5592 | 0.050 |
Why?
| | Up-Regulation | 2 | 2018 | 851 | 0.050 |
Why?
| | Epigastric Arteries | 1 | 2022 | 21 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2021 | 459 | 0.050 |
Why?
| | Endopeptidase K | 1 | 2021 | 18 | 0.040 |
Why?
| | Lung | 3 | 2024 | 4108 | 0.040 |
Why?
| | Ribonucleases | 1 | 2021 | 49 | 0.040 |
Why?
| | Light Coagulation | 1 | 2021 | 10 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2014 | 2929 | 0.040 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2021 | 33 | 0.040 |
Why?
| | Serum Response Factor | 1 | 2021 | 33 | 0.040 |
Why?
| | Fetoscopy | 1 | 2021 | 33 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1455 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2021 | 44 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1792 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2021 | 134 | 0.040 |
Why?
| | DNA Primers | 2 | 2012 | 511 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 889 | 0.040 |
Why?
| | Cardiac Output, Low | 1 | 2021 | 54 | 0.040 |
Why?
| | Body Temperature | 2 | 2012 | 228 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 1187 | 0.040 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2020 | 7 | 0.040 |
Why?
| | Cardiotonic Agents | 1 | 2021 | 95 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 86 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 185 | 0.040 |
Why?
| | Benzamides | 1 | 2021 | 224 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2025 | 0.040 |
Why?
| | Nitriles | 1 | 2021 | 205 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 283 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2020 | 126 | 0.040 |
Why?
| | Adult | 5 | 2024 | 40262 | 0.040 |
Why?
| | Androgens | 1 | 2021 | 186 | 0.040 |
Why?
| | Hominidae | 2 | 2014 | 87 | 0.040 |
Why?
| | Mass Spectrometry | 2 | 2014 | 744 | 0.040 |
Why?
| | Infant | 3 | 2020 | 10022 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2020 | 139 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 36 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 294 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2012 | 1304 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 115 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3119 | 0.040 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2018 | 35 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1715 | 0.030 |
Why?
| | Cell Cycle | 1 | 2021 | 596 | 0.030 |
Why?
| | Transcription Factors | 2 | 2019 | 1739 | 0.030 |
Why?
| | Freezing | 1 | 2018 | 85 | 0.030 |
Why?
| | Cohort Studies | 2 | 2022 | 5935 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 405 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11643 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 42 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 17 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 981 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1867 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2016 | 62 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 103 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 36 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 49 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 223 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.030 |
Why?
| | Critical Illness | 1 | 2022 | 889 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2104 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 2007 | 187 | 0.030 |
Why?
| | Pan troglodytes | 2 | 2007 | 63 | 0.030 |
Why?
| | Chemokines | 1 | 2016 | 218 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2879 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1134 | 0.030 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 881 | 0.030 |
Why?
| | Middle Aged | 4 | 2025 | 35762 | 0.030 |
Why?
| | Risk Factors | 2 | 2021 | 10699 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1833 | 0.030 |
Why?
| | Prognosis | 2 | 2015 | 4278 | 0.030 |
Why?
| | Hot Temperature | 1 | 2018 | 405 | 0.030 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 23 | 0.030 |
Why?
| | Retroelements | 1 | 2014 | 51 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1137 | 0.030 |
Why?
| | Immunologic Memory | 1 | 2016 | 366 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 226 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 22281 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 307 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2016 | 502 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2021 | 2494 | 0.020 |
Why?
| | Cadherins | 1 | 2015 | 200 | 0.020 |
Why?
| | Sirtuin 3 | 1 | 2014 | 60 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 508 | 0.020 |
Why?
| | Acetylation | 1 | 2014 | 252 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2917 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 612 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2012 | 89 | 0.020 |
Why?
| | CD146 Antigen | 1 | 2012 | 40 | 0.020 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2012 | 11 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6424 | 0.020 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 86 | 0.020 |
Why?
| | Mycoplasma pneumoniae | 1 | 2012 | 53 | 0.020 |
Why?
| | Peptide Library | 1 | 2012 | 95 | 0.020 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2012 | 55 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2014 | 256 | 0.020 |
Why?
| | Skinfold Thickness | 1 | 2012 | 43 | 0.020 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 25 | 0.020 |
Why?
| | Body Fat Distribution | 1 | 2012 | 45 | 0.020 |
Why?
| | Cystathionine beta-Synthase | 1 | 2012 | 65 | 0.020 |
Why?
| | Receptors, Complement 3b | 1 | 2012 | 80 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2022 | 17009 | 0.020 |
Why?
| | Adenoviridae | 1 | 2012 | 199 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 319 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 126 | 0.020 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2012 | 99 | 0.020 |
Why?
| | Citric Acid Cycle | 1 | 2011 | 59 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 147 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 322 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2012 | 185 | 0.020 |
Why?
| | Thermogenesis | 1 | 2011 | 45 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 437 | 0.020 |
Why?
| | Hindlimb | 1 | 2011 | 131 | 0.020 |
Why?
| | Exons | 1 | 2012 | 358 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 138 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 768 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2010 | 21 | 0.020 |
Why?
| | Young Adult | 2 | 2021 | 13990 | 0.020 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 27 | 0.020 |
Why?
| | Glycine | 1 | 2011 | 187 | 0.020 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2010 | 115 | 0.020 |
Why?
| | Arginine | 1 | 2011 | 262 | 0.020 |
Why?
| | Gene Library | 1 | 2010 | 126 | 0.020 |
Why?
| | NAD | 1 | 2010 | 81 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2010 | 93 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 508 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 368 | 0.020 |
Why?
| | Genes | 1 | 2010 | 226 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5389 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 442 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 661 | 0.020 |
Why?
| | Gestational Age | 1 | 2012 | 975 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 387 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 2048 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 523 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2430 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 302 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2010 | 327 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 525 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2008 | 121 | 0.020 |
Why?
| | Radiographic Image Enhancement | 1 | 2008 | 57 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2840 | 0.020 |
Why?
| | Genetic Diseases, Inborn | 1 | 2007 | 44 | 0.020 |
Why?
| | Neutrophils | 1 | 2012 | 1134 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2187 | 0.020 |
Why?
| | Mammography | 1 | 2008 | 165 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1084 | 0.020 |
Why?
| | Gene Rearrangement | 1 | 2007 | 155 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1406 | 0.010 |
Why?
| | Heat-Shock Response | 1 | 2006 | 77 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2061 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2004 | 15 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2004 | 20 | 0.010 |
Why?
| | Aged | 1 | 2025 | 25850 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 2004 | 7 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2006 | 342 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1054 | 0.010 |
Why?
| | Environment | 1 | 2006 | 305 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2004 | 117 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3313 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 276 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2006 | 374 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 539 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2004 | 322 | 0.010 |
Why?
| | Biomedical Research | 1 | 2007 | 709 | 0.010 |
Why?
| | Biological Evolution | 1 | 2004 | 488 | 0.010 |
Why?
| | Alcoholism | 1 | 2006 | 808 | 0.010 |
Why?
| | Sleep | 1 | 2006 | 901 | 0.010 |
Why?
| | Proteins | 1 | 2004 | 1021 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7155 | 0.010 |
Why?
|
|
Karimpour-Fard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|